Leuprolide Acetate Depot Kit
Product Images NDC 69097-909

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate Depot (NDC 69097-909). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Leuprolide Acetate Injection 01)

An instructional diagram showing components of the LEUPROLIDE ACETATE DEPOT kit by Cipla USA Inc. It includes a syringe with a plunger rod, backstop, and syringe barrel; a vial adapter; a needle; and a vial with a flip-off button. Each component is labeled to assist with assembly.*

FDA Label Image

Figure 2 (Leuprolide Acetate Injection 02)

The image shows two black-and-white panels demonstrating parts of preparation for an injection. The left panel depicts a gloved hand holding a vial labeled 'Leurolide' with a rubber stopper. The right panel shows a gloved hand holding a syringe with the plunger partially depressed and a black arrow pointing at the connection between the syringe and a white plastic injection device or needle safety mechanism.*

FDA Label Image

Figure 3 (Leuprolide Acetate Injection 03)

The image shows a gloved hand holding a vial labeled LEUPROLIDE ACETATE DEPOT, with a finger pressing down on a plastic flip-off cap indicated by a black arrow. This instructional illustration demonstrates how to remove or access the vial by pressing the cap.*

FDA Label Image

Figure 4 (Leuprolide Acetate Injection 04)

Two-panel instructional illustration showing preparation of LEUPROLIDE ACETATE DEPOT kit for use. The left panel depicts a gloved hand twisting open an ampule, while the right panel shows attachment of a syringe to a vial, demonstrating the steps to reconstitute or draw the medication.*

FDA Label Image

Figure 5 (Leuprolide Acetate Injection 05)

An instructional image showing gloved hands preparing an injection with a vial labeled for leuprolide acetate and a syringe. An arrow points to the plunger of the syringe being drawn back to fill it with the medication from the vial. The image is part of a medication administration kit for LEUPROLIDE ACETATE DEPOT by Cipla USA Inc.*

FDA Label Image

Figure 6 (Leuprolide Acetate Injection 06)

Illustration showing preparation of LEUPROLIDE ACETATE DEPOT kit for injection. The images show gloved hands assembling the vial and syringe components, demonstrating how to connect the syringe to the vial before use.*

FDA Label Image

Figure 7 (Leuprolide Acetate Injection 07)

Instructional photograph showing a gloved hand holding a syringe connected to a vial, with an arrow pointing to the syringe plunger being pulled back, likely demonstrating how to withdraw medication from the vial. The image relates to LEUPROLIDE ACETATE DEPOT kit preparation.*

FDA Label Image

Figure 7 (Leuprolide Acetate Injection 08)

An instructional image showing gloved hands preparing an injection. One hand holds a vial labeled LEUPROLIDE ACETATE DEPOT while the other hand is drawing liquid into a syringe with an attached needle. The image demonstrates the preparation process for administering leuprolide acetate injection from the CIPLA USA INC. kit.*

FDA Label Image

Figure 7 (Leuprolide Acetate Injection 09)

An instructional illustration showing a hand holding a syringe filled with liquid, featuring a long needle attached. The image likely demonstrates preparation or administration technique related to the LEUPROLIDE ACETATE DEPOT kit by Cipla USA Inc.*

FDA Label Image

Figure 7 (Leuprolide Acetate Injection 10)

An instructional diagram showing a hand holding a syringe positioned at a 90-degree angle for an injection. The diagram also includes an outline of the human buttocks, indicating the injection site on the upper outer quadrant.*

FDA Label Image

Chemical Structure Of Leuprolide Acetate (Leuprolide Acetate Injection 11)

Chemical structure of leuprolide acetate showing the molecular arrangement of its amino acid residues and the acetate component. The diagram includes labeled amino acids such as Pyr, His, Trp, Ser, Tyr, D-Leu, Leu, Arg, and Pro, illustrating the peptide nature of the compound.*

FDA Label Image

Figure 12 (Leuprolide Acetate Injection 12)

A line graph depicting testosterone concentration (ng/dL) over time (days) up to 168 days. The graph shows a high initial concentration near 600 ng/dL at day 0, with a sharp decrease by day 14, followed by very low concentrations maintained through day 168.*

FDA Label Image

Figure 12 (Leuprolide Acetate Injection 13)

FDA Label Image

Label A (Leuprolide Acetate Injection 14)

LEUPROLIDE ACETATE DEPOT 22.5 mg kit packaging label for depot suspension by Cipla USA Inc. Includes active ingredient leuprolide acetate for intramuscular injection. The label shows NDC 69097-909-50, storage instructions, manufacturer details, and contents including vial, syringe, and transfer device components.*

FDA Label Image

Label B (Leuprolide Acetate Injection 15)

Label for LEUPROLIDE ACETATE DEPOT kit showing a 2 mL mannitol solution (0.8% w/v) diluent for reconstitution of Leuprolide acetate Depot. The diluent is intended for intramuscular injection and storage instructions indicate 20°-25°C (68°-77°F). The label includes a barcode, lot and expiration fields, and states the syringe does not contain the active substance. Labeler is CIPLA USA INC.*

FDA Label Image

Label C (Leuprolide Acetate Injection 16)

Label for Leuprolide acetate depot suspension 22.5 mg by Cipla USA Inc. The label includes storage instructions for 20°-25°C (68°-77°F), batch printing area, barcode, and marks the product as sterile and prescription-only. Dimensions are 57mm by 21mm with an additional 10mm section for batch printing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.